SHRM words of wisdom...
I think the bottom has likely been reached. I dont think "certain" shareholders who own 17 million shares will try to sell at this level. I think the rapid selloff has achieved the intent of a healthy pullback. At this point, I dont think the other contenders have a chance to catch up to Champignon. SHRM has all the angles covered from research, to clinical trials, to product development, drug delivery systems, and most importantly licensed clinics (more are being established) that will evaluate clients, determine the best treatments and provide the necessary medical follow up to personalize treatment regimens accordingly. This summary was published after the Altmed acquisition: "The Company's recent, aggressive acquisition drive has assembled a roster of subsidiaries, consolidating their position as a leader in the race to bring bio-synthesized Federally approved drugs to a marketplace worth hundreds of billions of dollars. Champignon Brands Inc (CSE:SHRM | OTC:SHRMF) most recent acquisition, valued at approximately $47 million, AltMed Capital Corp. (Health Canada's only approved psychedelic medicine clinic) is led by Dr. McIntyre, widely regarded as the world's most recognized psychiatrist in relation to mood disorders. To help guide the rapid growth curve the company is riding, they've formed a Special Advisory Committee with multi-award winning board members qualified and experienced in areas such as medicine, psychology, mycology and pharmacology." So the thing to remember is the VALUE of the shares you are buying. It's not just the bricks and mortar. You are buying into the knowledge, skill and insight of seasoned professionals who are diligently buttoning up key acquisitions, engaged in acquiring/setting up the medical clinics, pursuing the necessary research and clinical trials that will set the baseline for the delivery of medical treatments. The stock has only been on the market a couple of months. It is a hidden gem. There is not enough historical data to evaluate the company as you would a company that has been around for years (no kidding). Once the analysts have a chance to understand the VALUE, the mission statement, and once the institutions get involved in investing in the company, watch out because the stock price will skyrocket. This will likely be one of the few and far between opportunities to buy this stock at a rock bottom price. The recent private placement had warrants that could be exercised at $1.15 a share at a certain point in time. Therefore I doubt that you will see the stock price dip below that level. If it does, it wont be for long. I wouldn't be worried about other Trippy stocks that are peddling packaged truffles in the Netherlands. They will eventually fizzle. SHRM has the others beat hands down. It's very scary to see the highs and lows in the stock price. If you have the stomach for it hang in there. I think the price rise in the next three years will be nothing short of spectacular. IMO.....